Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial: Leo AD,Jerusalem G,Petruzelka L,et al (Hosp of Prato,Italy; Centre Hospitalier Universitaire Sart Tilman and Liège Univ,Belgium; First Faculty of Medicine of Charles Univ,Prague, Czech Republic; et al) J Natl Cancer Inst 106:1-7, 2014 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial: Leo AD,Jerusalem G,Petruzelka L,et al (Hosp of Prato,Italy; Centre Hospitalier Universitaire Sart Tilman and Liège Univ,Belgium; First Faculty of Medicine of Charles Univ,Prague, Czech Republic; et al) J Natl Cancer Inst 106:1-7, 2014

摘要：
本文献已被 ScienceDirect 等数据库收录！